Biofrontera (BFRI) Stock Insights

BFRI price $0.89 +0.05 +5.55%

Ticker
BFRI
Price
$0.89
Change
+0.05 +5.55%
Market cap ?
$13.17M
P/E ?
-1.39
Forward P/E ?
4.43
Dividend yield ?
0.00%
Beta ?
0.88
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Stocklytics score
57
Value
58
Quality
32
Growth
80

Stocklytics score rationale: value 58, quality 32, growth 80.

Financials

2019202020212022202320242025
26181000188490002410000028674000340710003730300041705000

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn…

Fair value

BFRI fair value $6.17. Price $0.89. Price is 86% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.58M. Growth 10.66%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.11% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 14.85M. Net debt -231.00K. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare BFRI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.22—8.25M
2026-08-13-0.05-0.1012.00M9.50M
2026-05-14-0.41-0.1810.08M10.25M
2026-03-190.500.2017.10M16.15M
2025-11-12-0.59-0.606.99M7.00M
2025-08-13-0.57-0.459.03M8.30M
2025-05-15-0.47-0.218.59M10.55M
2025-03-21-0.190.0212.56M14.55M
2024-11-13-0.98-0.839.01M10.00M
2024-08-14-0.05-0.777.84M8.21M
2024-05-15-2.88-1.177.91M10.86M
2024-03-181.65-1.1910.59M11.52M
2023-11-10-4.64-3.788.90M8.43M
2023-08-11-7.23-5.145.85M6.20M
2023-05-12-4.40-3.908.73M9.15M
2023-03-08-2.09-2.2010.14M10.35M
2022-11-14-2.20-0.324.32M4.30M
2022-08-12-8.80-6.204.46M4.55M
2022-05-13-1.60-3.009.75M9.83M
2022-04-08-8.40-3.609.17M9.24M
2021-11-30-10.20-11.604.33M4.86M
2021-11-01-9.20—5.86M—
2021-03-31-0.01—4.74M—
2020-09-30-0.01—3.25M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-28Luebbert HermannBuy62.50K——
2026-07-28Luebbert HermannSell62.50K——
2026-07-28Leffler Eugene FrederickBuy31.25K——
2026-07-28Leffler Eugene FrederickSell31.25K——
2026-03-05Luebbert HermannBuy137.50K——
2026-03-05Luebbert HermannSell137.50K——
2026-03-05Leffler Eugene FrederickBuy87.50K——
2026-03-05Leffler Eugene FrederickSell87.50K——
2026-03-04Weber Kevin DanielBuy20.00K$0.9018.00K
2026-03-04Luebbert HermannBuy125.00K$0.90112.50K
2026-03-04Luebbert HermannBuy125.00K——
2026-03-04Leffler Eugene FrederickBuy62.50K——
2026-03-04Leffler Eugene FrederickBuy62.50K$0.9056.25K
2026-03-04Lanckriet HeikkiBuy20.00K$0.9018.00K
2026-03-04Hoffman Beth J.Buy20.00K$0.9018.00K
2026-03-04Jones George PatrickBuy50.00K$0.9045.00K
2026-03-04Jones George PatrickBuy50.00K——
2026-03-04BORER JOHN J IIIBuy20.00K$0.9018.00K
2025-09-16Link Christian Alexander AnsgarOther0——
2025-09-16VV Beteiligungen AktiengesellschaftOther0——
2025-09-16VV Beteiligungen AktiengesellschaftOther0——
2025-09-16VV Beteiligungen AktiengesellschaftOther4.83M$0.623.02M
2025-09-16DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTOther0——
2025-09-16DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTOther0——
2025-09-16DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTOther4.83M$0.623.02M
2025-09-16Plaggemars HansjoergOther0——
2025-09-16Zours Wilhelm Konrad ThomasOther0——
2025-09-16Zours Wilhelm Konrad ThomasOther0——
2025-09-16Zours Wilhelm Konrad ThomasOther4.83M$0.623.02M
2025-09-16DEUTSCHE BALATON AKTIENGESELLSCHAFTOther0——
2025-09-16DEUTSCHE BALATON AKTIENGESELLSCHAFTOther0——
2025-09-16DEUTSCHE BALATON AKTIENGESELLSCHAFTOther4.83M$0.623.02M
2025-09-16de la Huerta Martinez Maria del PilarOther0——
2025-09-16de la Huerta Martinez Maria del PilarOther4.83M$0.002.90K
2025-09-16Biofrontera AGBuy3.02K$0.002
2025-09-15Jones George PatrickBuy100.00K$1.00100.00K
2025-09-10Luebbert HermannBuy137.50K——
2025-09-10Luebbert HermannSell137.50K——
2025-09-10Leffler Eugene FrederickBuy87.50K——
2025-09-10Leffler Eugene FrederickSell87.50K——
2025-08-25Jones George PatrickOther0——
2025-07-22Weber Kevin DanielBuy20.00K$1.0020.00K
2025-07-22Luebbert HermannBuy125.00K$1.00125.00K
2025-07-22Luebbert HermannBuy125.00K——
2025-07-22Leffler Eugene FrederickBuy62.50K——
2025-07-22Leffler Eugene FrederickBuy62.50K$1.0062.50K
2025-07-22Lanckriet HeikkiBuy20.00K$1.0020.00K
2025-07-22Hoffman Beth J.Buy20.00K$1.0020.00K
2025-07-22BORER JOHN J IIIBuy20.00K$1.0020.00K
2025-06-30Biofrontera AGOther0——
2024-07-12Weber Kevin DanielBuy20.00K$1.3827.60K
2024-07-12Lanckriet HeikkiBuy20.00K$1.3827.60K
2024-07-12Leffler Eugene FrederickBuy175.00K$1.38241.50K
2024-07-12Leffler Eugene FrederickBuy175.00K——
2024-07-12Hoffman Beth J.Buy20.00K$1.3827.60K
2024-07-12Luebbert HermannBuy275.00K$1.38379.50K
2024-07-12Luebbert HermannBuy275.00K——
2024-07-12BORER JOHN J IIIBuy20.00K$1.3827.60K
2024-05-18Luebbert HermannBuy4.77K——
2024-05-18Luebbert HermannSell4.77K——
2023-07-03Lanckriet HeikkiOther0——
2023-05-18Monaco Erica L.Buy76.34K——
2023-05-18Monaco Erica L.Sell76.34K——
2023-05-18Luebbert HermannBuy95.42K——
2023-05-18Luebbert HermannSell95.42K——
2023-01-10Leffler Eugene FrederickBuy100.00K——
2022-11-14Gates Erica F.Other0——
2022-10-24Leffler Eugene FrederickOther———
2022-10-24Leffler Eugene FrederickOther0——
2022-05-18Wedge Loretta M.Buy22.00K$2.6157.42K
2022-05-18Weber Kevin DanielBuy22.00K$2.6157.42K
2022-05-18BORER JOHN J IIIBuy22.00K$2.6157.42K
2022-05-18Hoffman Beth J.Buy22.00K$2.6157.42K
2022-05-18Gates Erica F.Buy19.08K——
2022-05-18Monaco Erica L.Buy152.67K——
2022-05-18Hoffman Beth J.Buy22.00K——
2022-05-18Luebbert HermannBuy190.84K——
2022-05-18BORER JOHN J IIIBuy22.00K——
2022-05-18Wedge Loretta M.Buy22.00K——
2022-05-18Weber Kevin DanielBuy22.00K——
2022-03-02Weber Kevin DanielOther0——
2021-12-09Monaco Erica L.Buy56.69K$4.77270.41K
2021-12-09Gates Erica F.Buy20.41K$4.7797.35K
2021-12-09Luebbert HermannBuy113.38K$4.77540.82K
2021-12-09Luebbert HermannBuy113.38K——
2021-12-09Monaco Erica L.Buy56.69K——
2021-12-09Monaco Erica L.Buy56.69K$4.41250.00K
2021-12-09Gates Erica F.Buy20.41K$4.4190.00K
2021-11-02Wedge Loretta M.Other0——
2021-11-02BORER JOHN J IIIOther0——
2021-11-02Hoffman Beth J.Other0——
2021-10-28Biofrontera AGSell0——
2021-10-28Biofrontera AGOther0——
2021-10-28Luebbert HermannOther0——
2021-10-28Gates Erica F.Other0——
2021-10-28Monaco Erica L.Other0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 19, holders +7 vs prior quarter. Ownership 21.37%.

HolderSharesChangeChange %Value
ROSALIND ADVISORS, INC.1.28M111.65K+9.59%1.21M
AIGH CAPITAL MANAGEMENT LLC739.91K-175.30K-19.15%699.59K
RENAISSANCE TECHNOLOGIES LLC157.50K157.50KNew148.92K
CITADEL ADVISORS LLC104.94K104.94KNew99.22K
JANE STREET GROUP, LLC93.00K93.00KNew87.93K
GEODE CAPITAL MANAGEMENT, LLC76.69K-32.61K-29.84%72.51K
VANGUARD CAPITAL MANAGEMENT LLC71.38K19.13K+36.60%67.53K
VANGUARD FIDUCIARY TRUST CO61.70K00.00%58.37K
XTX TOPCO LTD51.89K29.40K+130.71%49.07K
HRT FINANCIAL LP43.35K43.35KNew40.00K
NORTHERN TRUST CORP31.54K31.54KNew29.82K
UBS GROUP AG18.52K16.98K+1102.47%17.52K
JONES FINANCIAL COMPANIES LLLP10.00K10.00KNew9.71K
SANCTUARY ADVISORS, LLC10.20K00.00%9.64K
GSA CAPITAL PARTNERS LLP10.02K10.02KNew9.00K
BLACKROCK, INC.4.62K00.00%4.37K
TOWER RESEARCH CAPITAL LLC (TRC)332332New314
SBI SECURITIES CO., LTD.30500.00%288
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD11New1
CITIGROUP INC0-11.84K-100.00%0
SUSQUEHANNA INTERNATIONAL GROUP, LLP0-38.57K-100.00%0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Biofrontera (BFRI) Stock Insights

BFRI$0.89+0.05 +5.55%

$13.17M

Market Cap

-1.39

P/E

4.43

Forward P/E

57

Score

Price History